Effect of Right-stellate Ganglion Block in Preventing Postoperative Nausea and Vomiting in Gynecological Laparoscopic Patients
1 other identifier
interventional
200
1 country
1
Brief Summary
Postoperative nausea and vomiting is one of the common postoperative complications. Studies have reported that without any antiemetic prevention treatment, the overall incidence of PONV in surgical operations is up to 20-30%, and the incidence of PONV in high-risk operations such as gynecological laparoscopy is higher. Postoperative nausea and vomiting can lead to perioperative complications and seriously affect the prognosis of patients. Although various preventive and therapeutic measures have been adopted in clinic, the incidence of perioperative nausea and vomiting is still high. Therefore, it is of great clinical significance to explore more effective and feasible methods to prevent the occurrence of PONV. Stellate ganglion block has been proved to be widely used in clinic and can play a positive role in multiple organs and systems of the whole body. In clinical work, stellate ganglion block is more widely used in the treatment of various pain, autonomic nerve disorders and other diseases. However, there are few clinical studies on whether stellate ganglion block can be used as an effective and feasible means to prevent postoperative nausea and vomiting and the related mechanisms to prevent the possible occurrence of nausea and vomiting. Therefore, this project aims to explore the preventive effect of stellate ganglion block on postoperative nausea and vomiting in gynecological laparoscopic surgery patients, and to explore its possible mechanism.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 9, 2023
CompletedFirst Submitted
Initial submission to the registry
April 14, 2024
CompletedFirst Posted
Study publicly available on registry
May 23, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 27, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 27, 2024
CompletedJuly 29, 2024
June 1, 2023
1.1 years
April 14, 2024
July 25, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
The incidence of postoperative nausea and vomiting
Postoperative nausea and vomiting is evaluated by follow-up
From end of surgery to 24 hours after surgery
Secondary Outcomes (8)
Incidence of nausea and vomiting during preemptive analgesia
From 0-10 minutes after preemptive analgesia
Intensity of nausea and vomiting during preemptive analgesia
From 0-10 minutes after preemptive analgesia
Intensity of nausea and vomiting during hospitalization
From end of surgery to 24 hours after surgery
Hemodynamic parameters
When patients enter the operation room (T0),Immediately before intubation(T1,about 30minutes after SGB),Immediately after intubation(T2,about 35minutes after SGB), trendelenburg position after completion (T3),At the end of the operation(T4)
Postoperative pain intensity
From end of surgery to 24 hours after surgery
- +3 more secondary outcomes
Study Arms (2)
Right-stellate ganglion block
EXPERIMENTALRight-stellate ganglion block was given 30 minutes before anesthesia induction
Blank control group
NO INTERVENTIONNo treatment was given 30 minutes before anesthesia induction
Interventions
The experimental group was given right stellate ganglion block 30 minutes before anesthesia
Eligibility Criteria
You may qualify if:
- Age ≥18 years and ≤ 70 years
- American Society of Anesthesiologists(ASA) physical status classification I-Ill.
- Voluntary participation and ability to understand and sign the informed consent form
- Patients undergoing gynecological laparoscopic surgery elective general anesthesia
You may not qualify if:
- Patients with obesity(BMI\>30kg/m2)
- Contraindicated to stellate ganglion block
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Second Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, 400000, China
Related Publications (1)
Liu Y, Piao G, Chen J, Duan G, Dan L, Chen G, Zhang Y. Effect of Right Stellate Ganglion Block on Preventing Postoperative Nausea and Vomiting in Gynecological Laparoscopic Patients: A Randomized Controlled Trial. Adv Ther. 2025 Mar;42(3):1537-1549. doi: 10.1007/s12325-025-03109-7. Epub 2025 Feb 10.
PMID: 39928244DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
ling Dan, BD
The Second Affilated Hospital of Chongqing Medical University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 14, 2024
First Posted
May 23, 2024
Study Start
June 9, 2023
Primary Completion
June 27, 2024
Study Completion
June 27, 2024
Last Updated
July 29, 2024
Record last verified: 2023-06
Data Sharing
- IPD Sharing
- Will share
all IPD that underlie results in a publication